In addition, some studies have shown that targeting CDK1 can reduce the efflux or metabolism of chemotherapy drugs by tumor cells, thereby increasing the accumulation and effect of chemotherapy drugs at the tumor site (Zeng et al., 2023). Here, CDK1 is linked to neoplasm.